Xiaoqing Wu

机构：University of Kansas, Beijing Normal University · ORCID：0000-0003-2076-4107

发表论文 173 篇 · 总被引 6065 次 · h-index 34

代表论文

• RNA-binding protein HuR inhibition induces multiple programmed cell death in breast and prostate cancer (2024 · Cell Communication and Signaling · 被引 14)
• HuR inhibition overcomes cFLIP-mediated doxorubicin resistance in triple-negative breast cancer (2024 · npj Precision Oncology · 被引 10)
• HPV prevalence and distribution characteristics in postmenopausal women from Nanjing, China (2024 · BMC Women s Health · 被引 9)
• HuR inhibition reduces post‐ischemic cardiac remodeling by dampening myocyte‐dependent inflammatory gene expression and the innate immune response (2025 · The FASEB Journal · 被引 6)
• Involvement of METTL3-mediated m6A methylation in the early development of porcine cloned embryos (2024 · Theriogenology · 被引 5)
• Intralesional injection of CpG ODNs complexed with glatiramer acetate mitigates systemic cytokine toxicities and synergistically advances checkpoint blockade efficacy (2025 · Drug Delivery and Translational Research · 被引 3)